摘要
Oligodendrocyte progenitor cells(OPCs) hold great promise for treatment of dysmyelinating disorders, such as multiple sclerosis and cerebral palsy. Recent studies on generation of human OPCs mainly use human embryonic stem cells(hESCs) or neural stem cells(NSCs) as starter cell sources for the differentiation process. However, NSCs are restricted in availability and the present method for generation of oligodendrocytes(OLs) from ESCs often requires a lengthy period of time. Here, we demonstrated a protocol to efficiently derive OPCs from human induced pluripotent stem cells(hiPSCs) by forced expression of two transcription factors(2TFs), Sox10 and Olig2. With this method, PDGFRα+ OPCs can be obtained in 14 days and O4^+ OPCs in 56 days.Furthermore, OPCs may be able to differentiate to mature OLs that could ensheath axons when co-cultured with rat cortical neurons. The results have implications in the development of autologous cell therapies.
Oligodendrocyte progenitor cells （OPCs） hold great promise for treatment of dysmyelinating disorders, such as multiple sclerosis and cerebral palsy. Recent studies on generation of human OPCs mainly use human embryonic stem cells （hESCs） or neural stem cells （NSCs） as starter cell sources for the differentiation process. However, NSCs are restricted in availability and the present method for generation of oligodendrocytes （OLs） from ESCs often requires a lengthy period of time. Here, we demonstrated a protocol to efficiently derive OPCs from human induced pluripotent stem cells （hiPSCs） by forced expression of two transcription factors （2TFs）, Sox10 and Olig2. With this method, PDGFR α＋ OPCs can be obtained in 14 days and O4＋ OPCs in 56 days. Furthermore, OPCs may be able to differentiate to mature OLs that could ensheath axons when co-cultured with rat cortical neurons. The results have implications in the development of autologous cell therapies.
基金
supported by the Stem Cell and Translation National Key Project(2016ZY05002449)
National Basic Research Program of China(2011CB965103,2012CBA01307)
National Natural Science Foundation of China(81661130160,81422014,81561138004)
Beijing Municipal Natural Science Foundation(5142005)
Royal Society-Newton Advanced Fellowship(NA150482)
